← Leaderboards
K Jin Kim
Panorama Research, Inc.
$2,694,894
Attributed
$2,694,894
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $655.5K · FY2005–12$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,694,894 · 6
By mechanism
R44$2,249,031 · 2
R43$445,863 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Property”
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
- Everette D Joseph · Howard University$250,079,293
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
PropertyXenograft ModelGrowth FactorProgramsScientific Advances And AccomplishmentsTumor XenograftFibroblast Growth Factor 2Fibroblast Growth FactorGrowthPharmaceutical PreparationsReceptorResearch StudyTumorMedicalAdvanced Malignant NeoplasmBinding (Molecular Function)Animal ModelClinical TrialsAntibodiesGrantCancer TypeMonoclonal AntibodiesCancer TherapyMalignant Neoplasms
Grant awards (8)
Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C$504,006
R44 · FY2012 · CA · contact PI
Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C$443,212
R44 · FY2011 · CA · contact PI
Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C$117,637
R43 · FY2010 · CA · contact PI
Monoclonal Antibody to FGF Receptor 2 for Treatment of Gastric and Other Cancers$122,226
R43 · FY2009 · CA · contact PI
Novel Monoclonal Antibody Therapy for Cancer$655,510
R44 · FY2006 · CA · contact PI
Novel Monoclonal Antibody Therapy for Cancer$646,303
R44 · FY2005 · CA
Novel Monoclonal Antibody Therapy for Cancer$100,000
R43 · FY2004 · CA
Novel Immunoadhesin Molecule for Cancer Therapy$106,000
R43 · FY2003 · CA